Abstract: A composition for the treatment of psoriasis, wherein the composition comprises a CB2 receptor binding agent, an immunosuppressive agent an oil; and a healing agent or an anti-inflammatory agent.

Abstract: A low-dose, sequenced, individualized chemotherapy dosing method wherein an identification is made of biomorphomolecular markers associated with a patient tumor to be treated, and a percentage of tumor cells expressing each of the biomorphomolecular markers is determined. A set of drugs is selected that are adapted to target the biomorphomolecular markers. A percent of peak plasma concentration is determined for each drug based on the percentage of cells respectively expressing each biomorphomolecular marker. The drugs are administered according to drug dosages based on the respective concentrations. The method further includes selecting a drug treatment period, selecting a drug repetition cycle within the drug treatment period, determining a drug dosage for each drug based on its concentration and the number of repetition cycles, determining a drug sequence to be given during each cycle, and determining a dosing time for each drug.

Abstract: A cancer therapy comprehensive method for characterizing a cancer tumor for medical diagnosis and treatment. The method facilitates determination of a cancer protein pattern based on detected nonbasal levels of biomolecular markers (BMMs) associated with a patient's tumor. A cancer therapy regimen is selected based on the cancer protein pattern for eradicating the tumor.

Abstract: A cancer therapy comprehensive assay kit for characterizing a cancer tumor for medical diagnosis and treatment. The assay kit facilitates determination of a cancer protein pattern based on detected levels of biomolecular markers (BMMs) associated with a patient's tumor. A cancer therapy regimen is selected based on the cancer protein pattern for eradicating the tumor.